Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide is a complex organic compound with the molecular formula C20H23NO3. It is a derivative of phenylacetamide, featuring a 3,4-dimethoxyphenyl group attached to the ethyl chain. N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide is known for its potential applications in the pharmaceutical industry, particularly as a precursor in the synthesis of certain psychoactive substances. Its structure includes two phenyl rings, an amide group, and two methoxy groups, which contribute to its unique chemical properties and potential therapeutic effects. However, it is important to note that the compound's specific uses and safety profile are subject to ongoing research and regulatory scrutiny.

4876-02-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 4876-02-2 Structure
  • Basic information

    1. Product Name: N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide
    2. Synonyms: benzeneacetamide, N-[2-(3,4-dimethoxyphenyl)ethyl]-
    3. CAS NO:4876-02-2
    4. Molecular Formula: C18H21NO3
    5. Molecular Weight: 299.3642
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 4876-02-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 510.4°C at 760 mmHg
    3. Flash Point: 262.5°C
    4. Appearance: N/A
    5. Density: 1.109g/cm3
    6. Vapor Pressure: 1.55E-10mmHg at 25°C
    7. Refractive Index: 1.554
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide(CAS DataBase Reference)
    11. NIST Chemistry Reference: N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide(4876-02-2)
    12. EPA Substance Registry System: N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide(4876-02-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 4876-02-2(Hazardous Substances Data)

4876-02-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4876-02-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,8,7 and 6 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4876-02:
(6*4)+(5*8)+(4*7)+(3*6)+(2*0)+(1*2)=112
112 % 10 = 2
So 4876-02-2 is a valid CAS Registry Number.

4876-02-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4876-02-2 SDS

4876-02-2Relevant articles and documents

Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment

Zhang, Rui,Li, Heng,Zhang, Xianglei,Li, Jian,Su, Haixia,Lu, Qiukai,Dong, Guangyu,Dou, Huixia,Fan, Chen,Gu, Zhanni,Mu, Qianwen,Tang, Wei,Xu, Yechun,Liu, Hong

, (2020/11/24)

Psoriasis is a kind of chronic inflammatory skin disorder, while the long-term use of conventional therapies for this disease are limited by severe adverse effects. Novel small molecules associated with new therapeutic mechanisms are greatly needed. It is known that phosphodiesterase 4 (PDE4) plays a central role in regulating inflammatory responses through hydrolyzing intracellular cyclic adenosine monophosphate (cAMP), making PDE4 to be an important target for the treatment of inflammatory diseases (e.g. psoriasis). In our previous work, we identified a series of novel PDE4 inhibitors with a tetrahydroisoquinoline scaffold through structure-based drug design, among which compound 1 showed moderate inhibition activity against PDE4. In this study, a series of novel tetrahydroisoquinoline derivatives were developed based on the crystal structure of PDE4D in complex with compound 1. Anti-inflammatory effects of these compounds were evaluated, and compound 36, with high safety, permeability and selectivity, exhibited significant inhibitory potency against the enzymatic activity of PDE4D and the TNF-α release from the LPS-stimulated RAW 264.7 and hPBMCs. Moreover, an in vivo study demonstrated that a topical administration of 36 achieved more significant efficacy than calcipotriol to improve the features of psoriasis-like skin inflammation. Overall, our study provides a basis for further development of tetrahydroisoquinoline-based PDE4 inhibitors against psoriasis.

Enhancement of the carbamate activation rate enabled syntheses of tetracyclic benzolactams: 8-oxoberbines and their 5- And 7-membered C-ring homologues

Kurouchi, Hiroaki

supporting information, p. 653 - 658 (2021/02/06)

A route to the direct amidation of aromatic-ring-tetheredN-carbamoyl tetrahydroisoquinoline substrates was developed. This route enabled general access to 8-oxoberberines and their 5- and 7- membered C-ring homologues. It overcomes the undesired tandem side-reactions that result in the destruction of the isoquinoline backbone, which inevitably occurred under our previously reported superacidic carbamate activation method.

Development of Pd(OAc)2-catalyzed tandem oxidation of C[sbnd]N, C[sbnd]C, and C(sp3)–H bonds: Concise synthesis of 1-aroylisoquinoline, oxoaporphine, and 8-oxyprotoberberine alkaloids

Nishimoto, Saeko,Nakahashi, Hiromichi,Toyota, Masahiro

supporting information, (2020/11/13)

A catalytic tandem oxidation of C[sbnd]N, C[sbnd]C, and C(sp3)–H bonds is developed. This tandem oxidation is applied to two-step total syntheses of papaveraldine and pulcheotine A. Additionally, the total synthesis of liriodenine is achieved in six steps from homopiperonyl alcohol and 2-bromophenylacetonitrile by applying this catalytic tandem oxidation. Moreover, the direct conversion of xylopinine to 8-oxypseudopalmatine in a 76% yield demonstrates the versatility of this catalytic reaction.

Synthesis of N-Heterocycles by Reductive Cyclization of Nitroalkenes Using Molybdenum Hexacarbonyl as Carbon Monoxide Surrogate

Su, Zhiyou,Liu, Bo,Liao, Hongze,Lin, Hou-Wen

supporting information, p. 4059 - 4066 (2020/06/21)

The development of a method that uses molybdenum hexacarbonyl [Mo(CO)6] as carbon monoxide (CO) surrogate for the palladium-catalyzed reductive cyclization of nitroalkenes into indoles or thienopyrroles is reported. Several types of nitroalkenes could be transformed into the desired products in excellent yields and in most cases with complete regioselectivities and higher yields than those previously reported with palladium/CO system.

Application of differential reactivity towards synthesis of lamellarin and 8-oxoprotoberberine derivatives: Study of photochemical properties of aryl-substituted benzofuran-8-oxoprotoberberines

Vyasamudri, Sameer,Yang, Ding-Yah

supporting information, p. 1092 - 1100 (2018/02/06)

A unique differential reactivity between dihydroisoquinolines and 3-nitrocoumarins was observed and was exploited for the efficient construction of lamellarins and their isomeric benzofuran-8-oxoprotoberberine derivatives under acid-catalyzed or base-promoted conditions. Further, these prepared aryl-substituted benzofuran-8-oxoprotoberberine derivatives bearing electron-donating substituents on benzofuran moiety are found to be benchtop stable but light-sensitive, and can undergo oxidative ring-opening reaction to give the corresponding keto products when exposed to visible light under aerobic conditions.

ORGANIC REACTIONS CARRIED OUT IN AQUEOUS SOLUTION IN THE PRESENCE OF A HYDROXYALKYL(ALKYL)CELLULOSE OR AN ALKYLCELLULOSE

-

Page/Page column 245; 246; 247, (2017/08/21)

The present invention relates to a method of carrying out an organic reaction in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose.

Designing new analogs for streamlining the structure of cytotoxic lamellarin natural products

Tangdenpaisal, Kassrin,Worayuthakarn, Rattana,Karnkla, Supatra,Ploypradith, Poonsakdi,Intachote, Pakamas,Sengsai, Suchada,Saimanee, Busakorn,Ruchirawat, Somsak,Chittchang, Montakarn

, p. 925 - 937 (2015/03/31)

Despite the therapeutic potential of marine-derived lamellarin natural products, their preclinical development has been hampered by their lipophilic nature, causing very poor aqueous solubility. In order to develop more drug-like analogs, their structure was streamlined in this study from both the cytotoxic activity and lipophilicity standpoints. First, a modified total synthetic route was successfully devised to construct a library of 59 systematically designed lamellarin analogs, which were then subjected to cytotoxicity and log P determinations. Along with the 25 first-generation lamellarins previously synthesized in our laboratory, the structure-activity and structure-lipophilicity relationships were extensively evaluated. Our results clearly indicated the additional structural requirements around the lamellarin skeleton which, when combined with those reported previously, can provide invaluable guidance for further modifications to increase the aqueous solubility of these compounds.

Amide and Peptide Bond Formation in Water at Room Temperature

Gabriel, Christopher M.,Keener, Megan,Gallou, Fabrice,Lipshutz, Bruce H.

supporting information, p. 3968 - 3971 (2015/09/01)

A general and environmentally responsible method for the formation of amide/peptide bonds in an aqueous micellar medium is described. Use of uronium salt (1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylaminomorpholinocarbenium hexafluorophosphate (COMU) as a coupling reagent, 2,6-lutidine, and TPGS-750-M represents mild conditions associated with these valuable types of couplings. The aqueous reaction medium is recyclable leading to low E Factors.

Synthesis of pyrido[2,1-a]isoquinolin-4-ones and oxazino[2,3-a]isoquinolin- 4-ones: New inhibitors of mitochondrial respiratory chain

Moreno, Laura,Cabedo, Nuria,Boulangé, Agathe,Párraga, Javier,Galán, Abraham,Leleu, Stéphane,Sanz, María-Jesús,Cortes, Diego,Franck, Xavier

, p. 69 - 76 (2013/10/01)

Benzo[a]quinolizine is an important heterocyclic framework that can be found in numerous bioactive compounds. The general scheme for the synthesis of these compounds was based on the preparation of the appropriate dihydroisoquinolines by Bischler-Napieral

Synthesis, DNA binding and antitumor evaluation of styelsamine and cystodytin analogues

Fong, Hugo K.H.,Copp, Brent R.

, p. 274 - 299 (2013/05/21)

A series of N-14 sidechain substituted analogues of styelsamine (pyrido[4,3,2-mn]acridine) and cystodytin (pyrido[4,3,2-mn]acridin-4-one) alkaloids have been prepared and evaluated for their DNA binding affinity and antiproliferative activity towards a pa

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4876-02-2